Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/46333
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVia Sosa, Ma. de los Ángeles-
dc.contributor.authorLopes, Natali-
dc.contributor.authorMarch Pujol, Marian-
dc.date.accessioned2013-09-25T13:58:49Z-
dc.date.available2013-09-25T13:58:49Z-
dc.date.issued2013-07-13-
dc.identifier.issn1471-2296-
dc.identifier.urihttp://hdl.handle.net/2445/46333-
dc.description.abstractBackground: Drug dosing errors are common in renal-impaired patients. Appropriate dosing adjustment and drug selection is important to ensure patients" safety and to avoid adverse drug effects and poor outcomes. There are few studies on this issue in community pharmacies. The aims of this study were, firstly, to determine the prevalence of dosing inadequacy as a consequence of renal impairment in patients over 65 taking 3 or more drug products who were being attended in community pharmacies and, secondly, to evaluate the effectiveness of the community pharmacist"s intervention in improving dosing inadequacy in these patients when compared with usual care. Methods: The study was carried out in 40 Spanish community pharmacies. The study had two phases: the first, with an observational, multicentre, cross sectional design, served to determine the dosing inadequacy, the drug-related problems per patient and to obtain the control group. The second phase, with a controlled study with historical control group, was the intervention phase. When dosing adjustments were needed, the pharmacists made recommendations to the physicians. A comparison was made between the control and the intervention group regarding the prevalence of drug dosing inadequacy and the mean number of drug-related problems per patient. Results: The mean of the prevalence of drug dosing inadequacy was 17.5% [95% CI 14.6-21.5] in phase 1 and 15.5% [95% CI 14.5-16.6] in phase 2. The mean number of drug-related problems per patient was 0.7 [95% CI 0.5-0.8] in phase 1 and 0.50 [95% CI 0.4-0.6] in phase 2. The difference in the prevalence of dosing inadequacy between the control and intervention group before the pharmacists" intervention was 0.73% [95% CI (−6.0) - 7.5] and after the pharmacists" intervention it was 13.5% [95% CI 8.0 - 19.5] (p < 0.001) while the difference in the mean of drug-related problems per patient before the pharmacists" intervention was 0.05 [95% CI( -0.2) - 0.3] and following the intervention it was 0.5 [95% CI 0.3 - 0.7] (p < 0.001). Conclusion: A drug dosing adjustment service for elderly patients with renal impairment in community pharmacies can increase the proportion of adequate drug dosing, and improve the drug-related problems per patient. Collaborative practice with physicians can improve these results.-
dc.format.extent9 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherBioMed Central-
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.1186/1471-2296-14-96-
dc.relation.ispartofBMC Family Practice, 2013, vol. 14, num. 96-
dc.relation.urihttp://dx.doi.org/10.1186/1471-2296-14-96-
dc.rightscc-by (c) Via Sosa, Ma. de los Ángeles et al., 2013-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)-
dc.subject.classificationPrescripció de medicaments-
dc.subject.classificationAtenció farmacèutica-
dc.subject.classificationFarmàcies-
dc.subject.classificationInsuficiència renal-
dc.subject.classificationPersones grans-
dc.subject.classificationAssaigs clínics-
dc.subject.classificationAssaigs clínics-
dc.subject.otherDrug prescribing-
dc.subject.otherPharmacy practice-
dc.subject.otherDrugstores-
dc.subject.otherRenal insufficiency-
dc.subject.otherOlder people-
dc.subject.otherClinical trials-
dc.subject.otherClinical trials-
dc.titleEffectiveness of a drug dosing service provided by community pharmacists in polymedicated elderly patients with renal impairment a comparative studyeng
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec627988-
dc.date.updated2013-09-25T13:58:49Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid23849005-
Appears in Collections:Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
Articles publicats en revistes (Bioquímica i Biomedicina Molecular)

Files in This Item:
File Description SizeFormat 
627988.pdf413.02 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons